Lansoprazole Bristol Laboratories (Lansoprazole)

Lansoprazole belongs to the proton pump inhibitor class. It binds irreversibly to the H+/K+ ATPase enzyme, also known as the gastric proton pump, on the surface of parietal cells. By blocking this final step in acid production, the drug markedly lowers both basal and stimulated gastric acid output, raising gastric pH and allowing ulcer healing and symptom relief.

The appropriate dose of Lansoprazole Bristol Laboratories is determined by the prescribing healthcare professional based on the specific indication, patient age, renal and hepatic function, and other clinical factors. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for Lansoprazole in pregnancy and lactation are limited. The medication should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers will evaluate individual circumstances before prescribing, and breastfeeding mothers should discuss potential exposure with their clinician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After receiving the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements if applicable) and assist with import documentation.

Lansoprazole, as a proton pump inhibitor, provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs, its efficacy and safety profile are similar, though individual patient response and drug‑interaction potential may differ. Choice of therapy is guided by clinical indication, patient tolerance, and possible interactions.

Store Lansoprazole Bristol Laboratories at ambient temperature, below 25 °C (77 °F). Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Lansoprazole is taken orally, usually as a tablet or capsule, with a glass of water. It is generally recommended to swallow the dosage form whole, without crushing or chewing, and to take it before a meal—often before breakfast—unless the prescriber provides alternative instructions.

Serious risks, though uncommon, include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated diarrhea, and low magnesium levels that can lead to muscle cramps, seizures, or cardiac arrhythmias. Patients should seek immediate medical attention if they experience symptoms like rash, persistent diarrhea, or unexplained weakness.

Lansoprazole should be avoided in individuals with known hypersensitivity to lansoprazole or any component of the formulation. Caution is also advised for patients with severe liver disease, those taking medications that have major interactions (e.g., ketoconazole, atazanavir), and patients with a history of C. difficile infection. The prescriber will assess suitability on a case‑by‑case basis.